CoChat

How long should a trial of escitalopram treatment be in patients with major depressive disorder, generalised anxiety disorder or social anxiety disorder? An exploration of the randomised controlled trial database

Baldwin, David S., Stein, Dan J., Dolberg, Ornah T., Bandelow, Borwin · 2009 · Human Psychopharmacology: Clinical and Experimental
Cited by 61

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

Objective: To extend the knowledge of course of improvement in patients with major depressive disorder (MDD), social anxiety disorder (SAD) or generalised anxiety disorder (GAD) participating in randomised placebo‐controlled trials (RCTs) and to infer the optimal duration of initial escitalopram treatment in clinical practice, after which intervention might be reasonable in case of non‐response. Methods: Post hoc analysis of pooled clinical trial database for escitalopram in MDD (14 studies), GAD (4 studies) and SAD (2 studies). ‘Onset’ of action was defined as a 20% or more decrease from baseline score in disorder‐specific psychopathological rating scales: ‘response’ as a 50% or more decrease from baseline score. Results: In MDD, the probability of responding at week 8 if no onset was apparent at week 2 was 43%; in patients with an onset of effect the probability was nearly 80%. Similar patterns were observed in GAD and SAD. The chance of responding beyond week 4 in MDD, GAD and SAD was 20% or less if no effect had occurred by week 2. Conclusions: The pattern of response in these RCTs suggests that in patients with MDD, GAD or SAD in wider clinical practice, a period of at least 4 weeks is worthwhile before considering further intervention. Copyright © 2009 John Wiley & Sons, Ltd.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/hup.1019

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 33

  1. Alexopoulos GS, 2004, Fixed dose of escitalopram (10 mg/day) and a flexible dosing regimen of sertraline (50–200 mg/day) in a randomised, double‐blind comparison in depressed patients, World J Biol Psychiatry, 5, 97
  2. Alexopoulos GS, 2004, A placebo‐controlled trial of escitalopram and sertraline in the treatment of major depressive disorder, Neuropsychopharmacology, 29, S87
  3. 10.1017/S1461145705005973 · DOI · Paper page
  4. 10.1017/S1461145701002565 · DOI · Paper page
  5. 10.1055/s-2006-946702 · DOI · Paper page
  6. 10.1080/10401230590932326 · DOI · Paper page
  7. 10.1185/030079906X115513 · DOI · Paper page
  8. 10.4088/JCP.v63n0410 · DOI · Paper page
  9. 10.1185/030079905X65484 · DOI · Paper page
  10. 10.1002/da.10146 · DOI · Paper page
  11. 10.1111/j.1600-0447.1985.tb02649.x · DOI · Paper page
  12. Everitt BS, 2004, Clinical Trials in Psychiatry
  13. 10.1016/j.jad.2004.11.011 · DOI
  14. Guy W, 1976, ECDEU Assessment Manual for Psychopharmacology, 76
  15. 10.1111/j.2044-8341.1959.tb00467.x · DOI · Paper page
  16. 10.1192/bjp.186.3.222 · DOI · Paper page
  17. 10.1007/s002130050578 · DOI
  18. 10.1097/00004850-200307000-00003 · DOI · Paper page
  19. 10.1002/da.20222 · DOI · Paper page
  20. 10.1192/bjp.134.4.382 · DOI · Paper page
  21. 10.1176/ajp.152.10.1500 · DOI · Paper page
  22. 10.1016/j.jpsychires.2008.02.002 · DOI
  23. 10.1176/appi.ajp.160.4.734 · DOI · Paper page
  24. 10.1002/da.20214 · DOI
  25. 10.4088/JCP.v64n1107 · DOI · Paper page
  26. 10.1055/s-2007-979551 · DOI · Paper page
  27. 10.1055/s-2007-979192 · DOI · Paper page
  28. 10.4088/JCP.v68n0805 · DOI · Paper page
  29. 10.4088/JCP.v63n0211 · DOI · Paper page
  30. 10.1097/00004850-199400940-00003 · DOI · Paper page
  31. 10.1097/00004850-200205000-00001 · DOI · Paper page
  32. 10.1002/mpr.150 · DOI
  33. 10.1016/S0022-3956(03)00053-0 · DOI

Cited by

See all 61

Metadata

Authors
Baldwin, D. S., Stein, D. J., Dolberg, O. T., & Bandelow, B.
Venue
Human Psychopharmacology: Clinical and Experimental
Publisher
Wiley
Published
2009-03-30
Volume
24
Issue
4
Pages
269-275
ISSN
  • 0885-6222 (ISSN-L)
  • 1099-1077
OpenAlex
W2151423698
Cited by
61
References
11
FWCI
3.84
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.